Lee D. Flowers - 08 Jun 2023 Form 4 Insider Report for HCW Biologics Inc. (HCWB)

Role
SVP of Business Development
Signature
/s/ Nicole Valdivieso, as Attorney-in-Fact for Lee D. Flowers
Issuer symbol
HCWB
Transactions as of
08 Jun 2023
Net transactions value
+$22,324
Form type
4
Filing time
09 Jun 2023, 20:00:30 UTC
Previous filing
03 Dec 2021
Next filing
11 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCWB Common Stock Options Exercise $750 +5,356 +5.6% $0.1400* 101,308 08 Jun 2023 Direct
transaction HCWB Common Stock Purchase $21,574 +10,000 +9.9% $2.16 111,308 08 Jun 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HCWB Stock Option (Right to Buy) Options Exercise $0 -5,356 -42% $0.000000 7,501 08 Jun 2023 Common Stock 5,356 $0.1400 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 20% of the total shares subject to the stock option grant vested on September 16, 2020; 20% of the total shares subject to the stock option grant vested on September 16, 2021; 25% of the total shares subject to the stock option grant will vest on September 16, 2022; and 35% of the total shares subject to the stock option grant will vest on September 16, 2023.